Muhammad Ammar Aslam, Hassaan Ahmad, Hamza Sultan Malik, Herlina Uinarni, Yasir Salam Karim, Yusuf Makhmudovich Akhmedov, Walid Kamal Abdelbasset, Sura A. Awadh, Mohammed Kadhem Abid, Yasser Fakri Mustafa, Bagher Farhood* and Amirhosein Sahebkar* Pages 5351 - 5369 ( 19 )
During the radiotherapeutic treatment of pediatric oncology patients, they would be at a latent risk of developing ionizing radiation-induced ototoxicity when the cochlea or auditory nerve is located within the radiation field. Sensorineural hearing loss (SNHL) is an irreversible late complication of radiotherapy, and its incidence depends on various factors such as the patient’s hearing sensitivity, total radiation dose to the cochlea, radiotherapy fractionation regimen, age and chemoradiation. Importantly, this complication exhibits serious challenges to adult survivors of childhood cancer, as it has been linked to impairments in academic achievement, psychosocial development, independent living skills, and employment in the survivor population. Therefore, early detection and proper management can alleviate academic, speech, language, social, and psychological morbidity arising from hearing deficits. In the present review, we have addressed issues such as underlying mechanisms of radiation-induced SNHL, audiometric findings of pediatric cancer patients treated with radiotherapy, and management and protection measures against radiation-induced ototoxicity.
Pediatric cancer, radiotherapy, sensorineural hearing loss, ototoxicity, chemoradiation, childhood cancer.